These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 26297049)
1. Coding-noncoding gene expression in intrahepatic cholangiocarcinoma. Wang J; Xie H; Ling Q; Lu D; Lv Z; Zhuang R; Liu Z; Wei X; Zhou L; Xu X; Zheng S Transl Res; 2016 Feb; 168():107-121. PubMed ID: 26297049 [TBL] [Abstract][Full Text] [Related]
2. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma. Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888 [TBL] [Abstract][Full Text] [Related]
3. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152. Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383 [TBL] [Abstract][Full Text] [Related]
4. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis. Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420 [TBL] [Abstract][Full Text] [Related]
5. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma. Zou W; Wang Z; Wang F; Li L; Liu R; Hu M BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689 [TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of long noncoding RNA and mRNA co-expression profile in intrahepatic cholangiocarcinoma tissue by RNA sequencing. Yang W; Li Y; Song X; Xu J; Xie J Oncotarget; 2017 Apr; 8(16):26591-26599. PubMed ID: 28427159 [TBL] [Abstract][Full Text] [Related]
7. Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma. Lv L; Wei M; Lin P; Chen Z; Gong P; Quan Z; Tang Z Am J Cancer Res; 2017; 7(3):688-699. PubMed ID: 28401021 [TBL] [Abstract][Full Text] [Related]
8. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes. Han BW; Ye H; Wei PP; He B; Han C; Chen ZH; Chen YQ; Wang WT BMC Genomics; 2018 Oct; 19(1):735. PubMed ID: 30305026 [TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma. Zhou D; Gao B; Yang Q; Kong Y; Wang W Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187 [TBL] [Abstract][Full Text] [Related]
10. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma. Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137 [TBL] [Abstract][Full Text] [Related]
11. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer. Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558 [TBL] [Abstract][Full Text] [Related]
12. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing. Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043 [TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma. Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506 [TBL] [Abstract][Full Text] [Related]
14. Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation. Shang D; Zheng T; Zhang J; Tian Y; Liu Y Tumour Biol; 2016 Sep; 37(9):12673-12684. PubMed ID: 27448299 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma. Song W; Miao DL; Chen L Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma. Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications. Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422 [TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo. Yao Y; Sun Y; Jiang Y; Qu L; Xu Y Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969 [TBL] [Abstract][Full Text] [Related]
19. Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion. Li Z; Li J; Ji D; Leng K; Xu Y; Huang L; Jiang X; Cui Y Gene; 2018 Mar; 645():131-136. PubMed ID: 29246536 [TBL] [Abstract][Full Text] [Related]
20. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma. Qiu G; Ma D; Li F; Sun D; Zeng Z Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]